Physician

Ferdy Santiago, MD

According to 2025 Medicare claims, Ferdy Santiago, MD (NPI: 1104053552) practices hematology/oncology in the Naples-Marco Island, FL market, with the plurality of this provider's patient population coming from Collier, FL. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 34102-5644. Santiago is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Santiago's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 882 traditional Medicare patients, billed 207,744 HCPCS/CPT codes, and received $3,034,923 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 688 prescription claims across 194 beneficiaries totaling $2,632,684 in drug costs, led by Ibrance (Palbociclib). 2023 DME data shows 64 claims. Open Payments data shows 72 records totaling $2,042. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $17,076 to $3,034,923. Similarly, Part D prescription costs have moved sharply higher in recent years, from $347 to $2,632,684. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.8M$5.5M2015 Medicare payment: $17,076 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $210,852 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,756,369 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,015,831 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,964,785 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,049,451 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $5,540,482 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,309,168 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,114,129 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,034,923 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015184,274$17,076
201613927,496$210,852
20171,146145,946$1,756,369
20181,311253,333$3,015,831
20191,507355,863$3,964,785
20201,258356,878$5,049,451
20211,282423,291$5,540,482
20221,122397,383$4,309,168
20231,086365,702$4,114,129
2024882207,744$3,034,923

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.6M$3.1M2015 Drug cost: $347 (USD; Tot_Drug_Cst)2016 Drug cost: $422,701 (USD; Tot_Drug_Cst)2017 Drug cost: $615,786 (USD; Tot_Drug_Cst)2018 Drug cost: $876,187 (USD; Tot_Drug_Cst)2019 Drug cost: $1,707,082 (USD; Tot_Drug_Cst)2020 Drug cost: $1,966,466 (USD; Tot_Drug_Cst)2021 Drug cost: $2,569,462 (USD; Tot_Drug_Cst)2022 Drug cost: $3,141,052 (USD; Tot_Drug_Cst)2023 Drug cost: $2,906,659 (USD; Tot_Drug_Cst)2024 Drug cost: $2,632,684 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151117$347
201677319$422,701
2017125504$615,786
2018152706$876,187
2019217978$1,707,082
2020199893$1,966,466
2021208884$2,569,462
2022228936$3,141,052
2023211902$2,906,659
2024194688$2,632,684

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$4.1K$8.1K2017 Medicare payment: $6,055 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $3,941 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $4,171 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $4,087 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,950 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,624 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $8,117 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R25$6,055
2018N/R23$3,941
2019N/R42$4,171
2020N/R49$4,087
2021N/R35$1,950
2022N/R78$2,624
2023N/R64$8,117
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more274488$97
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more433666$66
96372Injection of drug or substance under skin or into muscle217730$11
36415Insertion of needle into vein for collection of blood sample6921,869$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count6501,771$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IbrancePalbociclib26721$414,592
RevlimidLenalidomide19532$277,104
XtandiEnzalutamide20600$269,378
LenvimaLenvatinib Mesylate11330$265,425
SprycelDasatinib18540$230,849

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.72$2,042Fennec Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ferdy Santiago, MD?

Tedicare shows public-source Medicare data for Ferdy Santiago, MD (NPI 1104053552), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ferdy Santiago, MD have ACO affiliation data?

Ferdy Santiago, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Ferdy Santiago, MD?

Ferdy Santiago, MD is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Ferdy Santiago, MD have Open Payments data?

Ferdy Santiago, MD has 72 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.